CST3 and chronic kidney disease: The secondary objective was to investigate and compare the performance of aCG with other substitutes for renal function based on measured carboplatin exposure, including other weight descriptors, cystatin C, 24-hour creatinine clearance, and estimated GFR by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).